John Nawrocki, Hematology-Oncology Fellow MedStar Georgetown University Hospital, shared a post on X:
“Great finish to TexasLung26. Beyond the excellent sessions on immunotherapy, targeted therapies and perioperative NSCLC strategies, truly appreciated the chance to meet and connect with others passionate about advancing care.”
Other articles about lung cancer on OncoDaily.